Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Autoimmune hepatitis].

M H Heim1

  • 1Abteilung für Gastroenterologie und Hepatologie, Universitätsspital Basel. heimm@uhbs.ch

Therapeutische Umschau. Revue Therapeutique
|October 2, 2004
PubMed
Summary
This summary is machine-generated.

Autoimmune hepatitis (AIH) is a rare chronic liver disease diagnosed by excluding other causes and identifying specific autoantibodies. Treatment with corticosteroids and azathioprine is effective, though relapses can occur.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic profiling using plasma-derived cell-free DNA in therapy-naïve hepatocellular carcinoma patients: a pilot study.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

In vivo analysis at the cellular level reveals similar steatosis induction in both hepatitis C virus genotype 1 and 3 infections.

Journal of viral hepatitis·2017
Same author

Hepatitis B virus covalently closed circular DNA homeostasis is independent of the lymphotoxin pathway during chronic HBV infection.

Journal of viral hepatitis·2017
Same author

Impact of common risk factors of fibrosis progression in chronic hepatitis C.

Gut·2014
Same author

Hepatitis C virus dysregulates glucose homeostasis by a dual mechanism involving induction of PGC1α and dephosphorylation of FoxO1.

Journal of viral hepatitis·2013
Same author

Effect of antiviral therapy on circulating cytokeratin-18 fragments in patients with chronic hepatitis C.

Journal of viral hepatitis·2010
Same journal

[Multimodal Cardiac Imaging: New Developments for Clinical Practice].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Coronary angiography: From cardiac catheterization to advanced interventional cardiovascular imaging].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Athlete's heart: role of cardiac imaging in the prevention of sudden cardiac death].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Multimodal imaging in cardiac amyloidosis and cardiac sarcoidosis].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Inflammatory Heart Disease: The Role of Multimodality Cardiac Imaging in Myocarditis and Pericarditis].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

State-of-the-Art Cardiac Imaging

Therapeutische Umschau. Revue therapeutique·2026
See all related articles

Area of Science:

  • Hepatology
  • Immunology
  • Internal Medicine

Background:

  • Autoimmune hepatitis (AIH) is a chronic inflammatory liver disease characterized by hypergammaglobulinemia and autoantibodies.
  • It predominantly affects females and can manifest at any age, often presenting with non-specific symptoms.
  • Diagnosis requires excluding other causes of chronic hepatitis and is supported by serological markers and liver biopsy findings.

Purpose of the Study:

  • To provide a comprehensive overview of autoimmune hepatitis (AIH).
  • To discuss diagnostic criteria, including serological markers and histological features.
  • To outline current therapeutic strategies and their efficacy.

Main Methods:

  • Diagnosis relies on excluding viral, metabolic, genetic, and toxic etiologies of chronic liver injury.

Related Experiment Videos

  • Key diagnostic indicators include elevated immunoglobulin G levels, presence of antinuclear antibodies (ANA), smooth muscle antibodies (SMA), or liver-kidney microsomal antibodies (LKM).
  • Liver biopsy is crucial for assessing histological features, such as interface hepatitis and plasma cell infiltration.

    • Main Results:

    • Corticosteroids are effective in inducing remission in most AIH patients.
    • Combination therapy with azathioprine offers a favorable side effect profile and is recommended when feasible.
    • While relapses are common after initial treatment response, sustained disease control is achievable in the majority of cases.

    Conclusions:

    • AIH is a manageable chronic liver condition with established treatment protocols.
    • Early diagnosis and consistent management are key to preventing disease progression and complications.
    • Liver transplantation remains an effective option for patients with advanced disease or treatment failure, offering good long-term survival rates.